Retour
Également cotée sous
TRUMF
OTC
Fourchette du Jour
12,88 €
13,23 €
Fourchette 52 Semaines
12,15 €
20,12 €
Volume
23 251
Moyenne 50J / 200J
13,27 €
/
15,85 €
Clôture Précédente
13,15 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,2 | 0,2 |
| P/B | 0,0 | 3,0 |
| ROE % | 8,7 | 3,6 |
| Net Margin % | 11,3 | 3,8 |
| Rev Growth 5Y % | 14,0 | 9,9 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
157,00 €
148,22 € – 161,77 €
|
1,48T | 1 |
| FY2029 |
141,15 €
133,25 € – 145,44 €
|
1,37T | 1 |
| FY2028 |
120,96 €
114,19 € – 124,63 €
|
1,29T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | 22,79 € | 0,14 € | -99,4% |
| 2025-11-12 | 0,16 € | 0,16 € | -0,7% |
| 2025-08-07 | 0,17 € | 0,20 € | +20,8% |
| 2025-05-14 | 0,15 € | 0,08 € | -45,0% |
| 2025-02-13 | 0,16 € | 0,16 € | -2,9% |
| 2024-11-07 | 0,15 € | 0,13 € | -13,5% |
| 2024-08-08 | 0,13 € | 0,15 € | +12,1% |
| 2024-05-27 | 0,12 € | 0,12 € | -5,1% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,30%
Growth (3Y)
-31,08%
Growth (5Y)
-19,44%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Sep 30, 2025 | — | 0,09 € | 1,10% |
| Mar 31, 2025 | Jul 09, 2025 | 0,09 € | 0,94% |
| Sep 30, 2024 | Dec 18, 2024 | 0,09 € | 0,71% |
| Mar 27, 2024 | Jul 12, 2024 | 0,09 € | 1,05% |
| Sep 28, 2023 | Dec 19, 2023 | 0,30 € | 2,25% |
| Mar 30, 2023 | Jul 13, 2023 | 0,29 € | 2,15% |
| Sep 29, 2022 | Dec 20, 2022 | 0,28 € | 1,95% |
| Mar 29, 2022 | Jul 08, 2022 | 0,27 € | 1,75% |
| Sep 28, 2021 | Dec 20, 2021 | 0,28 € | 1,13% |
| Mar 29, 2021 | Jul 08, 2021 | 0,27 € | 1,49% |
| Sep 28, 2020 | Dec 17, 2020 | 0,27 € | 1,30% |
| Mar 27, 2020 | Jul 13, 2020 | 0,26 € | 1,60% |
| Sep 26, 2019 | Dec 19, 2019 | 0,26 € | 1,58% |
| Mar 28, 2019 | Jul 09, 2019 | 0,50 € | 1,70% |
| Sep 26, 2018 | Dec 20, 2018 | 0,24 € | 1,62% |
| Mar 27, 2018 | Jul 10, 2018 | 0,25 € | 1,75% |
| Sep 27, 2017 | Dec 01, 2017 | 0,20 € | 2,01% |
| Mar 28, 2017 | Jul 13, 2017 | 0,20 € | 2,17% |
| Sep 27, 2016 | Dec 21, 2016 | 0,18 € | 1,94% |
| Mar 28, 2016 | Jul 12, 2016 | 0,20 € | 1,95% |
Points Clés
Revenue grew 13,98% annually over 5 years — strong growth
Debt/Equity of 0,13 — conservative balance sheet
Generating 128,44B in free cash flow
P/E of 0,17 — trading at a low valuation
Cash machine — converts 109,80% of earnings into free cash flow
Capital efficient — spends only 7,95% of revenue on capex
Croissance
Revenue Growth (5Y)
13,98%
Revenue (1Y)12,40%
Earnings (1Y)9,97%
FCF Growth (3Y)68,27%
Qualité
Return on Equity
8,68%
ROIC7,66%
Net Margin11,29%
Op. Margin15,22%
Sécurité
Debt / Equity
0,13
Current Ratio3,00
Interest Coverage25,24
Valorisation
P/E Ratio
0,17
Forward P/E0,14
P/B Ratio0,01
EV/EBITDA-0,18
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,40% | Revenue Growth (3Y) | 12,40% |
| Earnings Growth (1Y) | 9,97% | Earnings Growth (3Y) | 14,44% |
| Revenue Growth (5Y) | 13,98% | Earnings Growth (5Y) | 10,92% |
| Profitability | |||
| Revenue (TTM) | 1,04T | Net Income (TTM) | 116,98B |
| ROE | 8,68% | ROA | 6,40% |
| Gross Margin | 54,11% | Operating Margin | 15,22% |
| Net Margin | 11,29% | Free Cash Flow (TTM) | 128,44B |
| ROIC | 7,66% | FCF Growth (3Y) | 68,27% |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 3,00 |
| Interest Coverage | 25,24 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,30% |
| Dividend Growth (3Y) | -31,08% | Dividend Growth (5Y) | -19,44% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,17 | Forward P/E | 0,14 |
| P/B Ratio | 0,01 | P/S Ratio | 0,02 |
| PEG Ratio | 3,39 | Forward PEG | N/A |
| EV/EBITDA | -0,18 | Fwd EV/EBITDA | -0,10 |
| Forward P/S | 0,02 | Fwd Earnings Yield | 714,29% |
| FCF Yield | 662,65% | ||
| Market Cap | 19,38B | Enterprise Value | -27,65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,04T | 921,86B | 820,21B | 703,30B | 613,84B |
| Net Income | 116,98B | 106,37B | 89,33B | 88,81B | 77,27B |
| EPS (Diluted) | 78,99 | 71,47 | 59,48 | 58,69 | 51,05 |
| Gross Profit | 560,67B | 479,18B | 417,37B | 369,34B | 326,62B |
| Operating Income | 157,67B | 140,10B | 117,33B | 115,96B | 98,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,83T | 1,83T | 1,60T | 1,47T | 1,35T |
| Total Liabilities | 459,86B | 504,31B | 491,16B | 461,38B | 494,53B |
| Shareholders' Equity | 1,37T | 1,33T | 1,11T | 1,01T | 856,66B |
| Total Debt | 174,84B | 268,55B | 231,94B | 259,01B | 293,08B |
| Cash & Equivalents | 221,87B | 204,88B | 187,32B | 205,25B | 200,77B |
| Current Assets | 723,50B | 722,12B | 611,40B | 558,71B | 523,97B |
| Current Liabilities | 240,97B | 379,15B | 218,00B | 177,72B | 211,37B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026